Theravance Biopharma (TBPH) Other Non Operating Income (2014 - 2026)

Theravance Biopharma (TBPH) has reported Other Non Operating Income for 13 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income rose 220.87% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $12.2 million (up 179.25% YoY), while the FY2025 annual figure was $10.2 million, up 108.42% from the prior year.
• Other Non Operating Income slipped to $3.0 million in Q1 2026 per TBPH's latest filing, from $3.6 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $4.1 million in Q3 2025 and bottomed at -$7.9 million in Q4 2022.
• Historically, Other Non Operating Income has averaged $1.4 million across 5 years, with a median of $1.8 million in 2023.
• On a YoY basis, Other Non Operating Income climbed as much as 1761.45% in 2022 and fell as far as 2424.56% in 2022.
• Theravance Biopharma's Other Non Operating Income stood at -$7.9 million in 2022, then surged by 123.51% to $1.8 million in 2023, then sank by 51.06% to $904000.0 in 2024, then surged by 302.54% to $3.6 million in 2025, then slipped by 17.2% to $3.0 million in 2026.
• Business Quant data shows TBPH's Other Non Operating Income at $3.0 million in Q1 2026, $3.6 million in Q4 2025, and $4.1 million in Q3 2025.